Wild type and YMDD variant of hepatitis B virus: no difference in viral kinetics on lamivudine/tenofovir therapy in HIV-HBV co-infected patients.

de Vries-Sluijs, T E M S; van der Eijk, A A; Hansen, B E; Osterhaus, A D M E; de Man, R A; van der Ende, M E

de Vries-Sluijs, T E M S; van der Eijk, A A; Hansen, B E; Osterhaus, A D M E; de Man, R A; van der Ende, M E.

Affiliation

de Vries-Sluijs TE; Department of Internal Medicine - Infectious Diseases, ERASMUS MC, University Medical Center Rotterdam, The Netherlands. t.sluijs@erasmusmc.nl

J Clin Virol ; 36(1): 60-3, 2006 May.

Article in En | MEDLINE | ID: mdl-16418013

Subject(s)

Adenine/analogs & derivatives; Anti-HIV Agents/therapeutic use; HIV Infections/complications; Hepatitis B virus/drug effects; Hepatitis B virus/genetics; Hepatitis B/drug therapy; Lamivudine/therapeutic use; Organophosphonates/therapeutic use; Adenine/therapeutic use; Adult; DNA, Viral/blood; Drug Resistance, Viral/genetics; Genetic Variation; HIV Infections/drug therapy; Hepatitis B/complications; Humans; Kinetics; Male; Middle Aged; RNA, Viral/blood; Tenofovir

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Adenine / HIV Infections / Hepatitis B virus / Lamivudine / Anti-HIV Agents / Organophosphonates / Hepatitis B Limits: Adult / Humans / Male / Middle aged Language: En Journal: J Clin Virol Journal subject: VIROLOGIA Year: 2006 Type: Article Affiliation country: Netherlands

Search on Google

XML

PubMed Links